Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
89 participants
INTERVENTIONAL
2023-09-15
2024-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Iron Reduction for the Treatment of Diabetes and Nonalcoholic Fatty Liver Disease
NCT03696797
Effects of Phlebotomy on Insulin Sensitivity in Insulin Resistance-associated Hepatic Iron Overload Patients
NCT01572818
Iron and Insulin Resistance in Overweight and Obese Humans
NCT03348020
Effects of Blood Letting in Metabolic Syndrome
NCT01328210
Mechanisms of Insulin Resistance in Humans
NCT00330967
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Insulin sensitivity during an oral glucose tolerance test (OGTT) and isotopically measured rate of appearance of endogenous and exogenous glucose will be measured on 2 occasions.
1. Two weeks prior to DON/CONT
2. Two weeks after to DON/CONT
Indexes of the bodily iron stores will be measured after DON/CONT to evaluate if the primary treatment was effective.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DONATION GROUP
Participants will be measured before and after a standard blood bank donation (450 mL of whole blood withdrawal)
Whole blood standard donation
Effects of a standard whole blood donation on iron stores and insulin sensitivity.
CONTROL GROUP
Participants will be measured before and after a sham blood donation (0 mL of whole blood withdrawal)
Whole blood standard donation
Effects of a standard whole blood donation on iron stores and insulin sensitivity.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Whole blood standard donation
Effects of a standard whole blood donation on iron stores and insulin sensitivity.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* IMC\>25
* fasting blood glucose 100-125 mg/dL
* glycosylated hemoglobin levels between 5.7-6.4%
Exclusion Criteria
* insulin treatment for diabetes
* anemia
* hereditary hemochromatosis
* heart disease
* familial hypertriglyceridemia or hypobetalipoproteinemia
* any disease that requires medication that interferes with iron or glucose metabolism
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
SESCAM Centro Regional de Transfusión Toledo-Guadalajara.
UNKNOWN
University of Castilla-La Mancha
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ricardo Mora
Director of Exercise Physiology Laboratory
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Castilla-La Mancha (Exercise Physiology Lab)
Toledo, Toledo, Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Moreno-Navarrete, J. M., M. Moreno, J. Puig, G. Blasco, F. Ortega, G. Xifra, W. Ricart and J. M. Fernandez-Real (2017).
Van Pelt, D. W., S. A. Newsom, S. Schenk and J. F. Horowitz (2015).
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CEIC-CHUT-969
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.